Safety Profile of Azathioprine among Inflammatory Bowel Disease Patients in Addis Ababa University, College of Medicine And Health Science, School of Medicine, Department of Internal Medicine, Gastroenterology & Hepatology Unit, Addis Ababa. Ethiopia. Two Year Retrospective Study
| dc.contributor.advisor | Rezene Berhe | |
| dc.contributor.author | Selamawit Walle | |
| dc.date.accessioned | 2025-08-12T15:27:30Z | |
| dc.date.available | 2025-08-12T15:27:30Z | |
| dc.date.issued | 2024-10-23 | |
| dc.description.abstract | Azathioprine, is the pro drug of 6-mercaptopurine which is a purine analogue. It inhibits cell growth by directly interfering with nucleic acid synthesis. It has long been a cornerstone in the management of inflammatory bowel disease (IBD), encompassing both Crohn's disease and ulcerative colitis. As with any potent medication, understanding its safety profile is paramount in optimizing patient care. | |
| dc.identifier.uri | https://etd.aau.edu.et/handle/123456789/6340 | |
| dc.language.iso | en_US | |
| dc.publisher | Addis Ababa University | |
| dc.subject | Azathioprine | |
| dc.subject | Inflammatory bowel disease | |
| dc.title | Safety Profile of Azathioprine among Inflammatory Bowel Disease Patients in Addis Ababa University, College of Medicine And Health Science, School of Medicine, Department of Internal Medicine, Gastroenterology & Hepatology Unit, Addis Ababa. Ethiopia. Two Year Retrospective Study | |
| dc.type | Thesis |